General Information of the Compound
| Compound ID |
CP0573075
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R)-4-[(1S,6R)-5-[(2S)-2-(4-chlorophenyl)-3-(3-oxabicyclo[3.1.0]hexan-6-ylamino)propanoyl]-2,5-diazabicyclo[4.1.0]heptan-2-yl]-5-methyl-6,8-dihydro-5H-pyrido[2,3-d]pyrimidin-7-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H31ClN6O3
|
||||||||||||||||||
| Molecular Weight |
523.037
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1CC(=O)Nc2ncnc(N3CCN([C@@H]4C[C@H]34)C(=O)[C@H](CNC3C4COCC34)c3ccc(Cl)cc3)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H31ClN6O3/c1-14-8-22(35)32-25-23(14)26(31-13-30-25)33-6-7-34(21-9-20(21)33)27(36)17(15-2-4-16(28)5-3-15)10-29-24-18-11-37-12-19(18)24/h2-5,13-14,17-21,24,29H,6-12H2,1H3,(H,30,31,32,35)/t14-,17-,18?,19?,20+,21-,24?/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CMAWINZBRBLNOW-GKTDGSLASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Protein ID: PT01131, RAC-beta serine/threonine-protein kinase
Protein ID: PT01022, RAC-gamma serine/threonine-protein kinase